Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion

Details for Australian Patent Application No. 2001275411 (hide)

Owner Bristol-Myers Squibb Company

Inventors Peach, Robert J.; Todderud, Charles Gordon; Townsend, Robert M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001275411

PCT Pub. Number WO01/95928

Priority 60210671 09.06.00 US

Filing date 8 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 28 April 2005

International Classifications

A61K 038/17 Medicinal preparations containing peptides - from animals

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 014/705 Peptides having more than 20 amino acids

A61P 037/00 Drugs for immunological or allergic disorders

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

28 April 2005 Application Accepted

  Published as AU-B-2001275411

25 August 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275412

2001275410-Multilayer abuse resistant oxygen and moisture barrier packaging film